Clinical trial
Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical…
NCT00003977 · Steward St. Elizabeth's Medical Center of Boston, Inc., Other · Completed
Key facts
| NCT number | NCT00003977 |
|---|---|
| Title | Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer |
| Official title | A Phase I Study of Immunization With Alternating Human Papillomavirus E7 Lipopeptide Epitope Vaccine and Dendritic Cells Presenting the E7 Epitope for the Treatment of Recurrent or Persistent Cervical Cancer |
| Lead sponsor | Steward St. Elizabeth's Medical Center of Boston, Inc., Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cervical Cancer |
| Intervention type | Biological, Procedure |
| Interventions | human papillomavirus 16 E7 peptide, in vitro-treated peripheral blood stem cell transplantation |
| Start date | Nov 1, 1999 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 9, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: